Neutrolis Appoints Mikael Dolsten As Executive Director On Board
23 Feb 2026 //
GLOBENEWSWIRE
Neutrolis Show 1st-in-Human Data on NET Clearance in Autoimmunity
29 Oct 2025 //
GLOBENEWSWIRE
Neutrolis Presents Clinical Results At Acr Convergence 2025
13 Oct 2025 //
GLOBENEWSWIRE
Neutrolis Licenses UIC Patent for Dry Eye Disease Therapy
23 Dec 2024 //
GLOBENEWSWIRE
Neutrolis Expands Leadership to Drive Non-Immunosuppressive Therapy
18 Dec 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support